The Clinerion Patient Finder identifies suitable clinical study candidates for given protocols by automated screening of real-time electronic health records (EHRs). The Patient Finder enables faster and more efficient search and identification, leading to more patients enrolled.

The Clinerion Patient Finder tool is able to query hospital information systems across Clinerion’s networked hospitals in real-time, using study protocols generated by Clinerion’s Protocol Designer. The tool provides automated alerts for hospital staff to identify patients entering hospital systems in time and enroll them for clinical research trials before traditional treatment is initiated. Real-time identification of eligible candidate patients for recruitment allows primary investigators and study nurses at trial sites to track and trace patients instantaneously, in real-time, with 24/7 notification of new, eligible patients.

Experience shows that the Patient Finder typically identifies 10 to 30 times more patients than found with classical manual screening, in a fraction of the time: minutes instead of the 3-6 months of a traditional manual search process.

Clinerion's technology solution is a hybrid system with all sensitive patient information processed within a hospital group's infrastructure. To clinical trial staff it is available as an easy-to-use, web-based application that can be employed for all disease indications, in interventional and observational trials, in virtually all hospital systems, and in acute and out-patient settings.

 

Benefits of the Patient Finder:

To clinical trial sponsors:
  • Quicker results, can run time-critical trials due to shorter time and real-time alerts
  • Find 10-30 times more matching patients in minutes/hours
To physicians and hospitals:
  • Find 10-30 times more matching patients in minutes/hours
  • Real-time alerts when eligible patients found
  • Supports investigator initiated internal clinical research with an established and tested service: no need to develop your own system
  • Can run time-critical trials due to shorter time and real-time alerts
  • Access innovative medication for patients